本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

福泰制药

383.12
-3.9900-1.03%
盘后383.600.4800+0.13%19:59 EDT
成交量:339.42万
成交额:13.06亿
市值:982.28亿
市盈率:27.23
高:389.46
开:388.60
低:382.60
收:387.11
52周最高:519.88
52周最低:362.50
股本:2.56亿
流通股本:2.56亿
量比:2.09
换手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):14.07
每股收益(LYR):-2.0768
净资产收益率:22.77%
总资产收益率:13.09%
市净率:5.72
市盈率(LYR):-184.48

数据加载中...

2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

重要事件披露

Form 8-K - Current report